Table 1.
Summary of the selected adipokines alteration in response to MetS, RT, and AT.
| Adipokines | MetS | AT | Possible Mechanisms | RT | Possible Mechanisms |
|---|---|---|---|---|---|
| Irisin | Decrease | Increase | Decreased body fat percentage and insulin resistance | Increase | Improved body composition and insulin function |
| Visfatin | Increase | Decrease | Body fat mass reduction | Decrease | Improved body composition |
| Resistin | Increase | Decrease | Improved insulin resistance, inflammatory markers, and glycosylated hemoglobin | Decrease | Decreased body fat percentage and insulin resistance |
| Chemerin | Increase | Decrease | Decreased body fat percentage and improved lipid profile | Decrease | Decreased body fat percentage and insulin resistance |
| Retinol Binding Protein 4 (RBP4) | Increase | Decrease | Decreased body fat percentage | Decrease | Decreased glucose and improved insulin sensitivity |
| Interleukin 8 (IL-8) | Increase | Decrease | Decreased body fat mass and inflammatory markers | Decrease | Decreased body fat mass and increased proinflammatory cytokines |
| Interleukin 10 (IL-10) | Increase | Decrease | Weight loss and body fat percentage reduction | Decrease | Body fat mass reduction |
| Interferon gamma (IFN-γ) | Increase | Decrease | Decreased inflammatory markers | Decrease | Improved body composition and insulin sensitivity |
| C1q/TNF-related protein (CTRP4) | Increase | Decrease | Decreased insulin and increased fat oxidation | Decrease | Decreased body fat percentage and insulin resistance |